Karyopharm Therapeutics
KPTI
KPTI
73 hedge funds and large institutions have $251M invested in Karyopharm Therapeutics in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $345M → $251M (-$93.3M)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
73
Holding in Top 10
–
Calls
$1.24M
Puts
$816K
Top Buyers
| 1 | +$4.1M | |
| 2 | +$3.48M | |
| 3 | +$2.56M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$2.41M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.37M |
Top Sellers
| 1 | -$4.37M | |
| 2 | -$3.46M | |
| 3 | -$1.13M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$962K |
| 5 |
SCA
Secor Capital Advisors
New York
|
-$781K |